The vaccine against bronchiolitis is now a reality. Until now, the vaccine was administered only to children who had a risk pathology, but since October 1, it has been universal for all babies under 6 months of age and newborns. Thus, the Valencian government goes from protecting 1,000 children to doing the same with 36,000. This occurs because the medication has changed and the new drug is given in a single dose (instead of 5 injections), which facilitates mass vaccination for all younger babies. And it also ensures protection for 5 months. But how, when and where? The key is the age of the baby.
Related
For newborn babies
The campaign is designed so that babies newborns receive the vaccine before leaving the hospital, in the maternity hospitals themselves. Thus, until March 31, 2024. The family will receive the pertinent information and, along with other tests (such as the well-known heel test), vaccination against RSV (Respiratory Syncytial Virus) will be included before the baby is given birth. discharged from the hospital.
For babies born between April 1 and September 30, 2023
Furthermore, minors born between April 1, 2023 and September 30, 2023 They will be immunized in Primary Care centers by appointment or taking advantage of scheduled consultations. Thus, during the first months of life, and coinciding with pediatric check-ups and the rest of the vaccination schedule, health personnel at health centers will inform and include the RSV vaccine since it is compatible with other vaccines.
For minors included in risk groups
Los minors included in risk groups, for their part, will be immunized in the health centers that usually care for the child, taking special advantage of the health checks planned for these months. And if no appointment is scheduled, you must be specifically scheduled for immunization or referred to the corresponding health center to be administered.
Is my baby ‘at risk’?
The department explains that the child population with high risk of severe RSV disease includes “to premature infants of less than 35 weeks (including those with a gestational age of less than 29 weeks); patients with congenital heart disease with significant hemodynamic impairment; patients with bronchopulmonary dysplasia; and patients with other underlying pathologies that pose a high risk of suffering from bronchiolitis due to RSV, such as those with severe immunosuppression, inborn errors of metabolism, severe neuromuscular and pulmonary diseases, genetic syndromes with relevant respiratory problems, Down syndrome, cystic fibrosis and those in palliative care.
2023-10-05 07:00:00
#vaccinate #child #bronchiolitis
